Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individual Differences in the Acute Response to Experimentally Induced Inflammation
NCT06618716Completed
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Endotoxin with Placebo (2 arms). Primary endpoints: Behavioral response to inflammation, Microcirculatory changes in skin and 1 more. Started Sep 2024; status: completed.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NCT06618716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06618716.